Research programme: GTP-binding protein inhibitors - IpsenAlternative Names: BIM-46174; BIM-46187
Latest Information Update: 10 Oct 2016
At a glance
- Originator Ipsen
- Developer Institut Henri Beaufour-Ipsen; Ipsen; Oncodesign Biotechnology
- Class Imidazoles; Small molecules
- Mechanism of Action G protein-coupled receptor modulators; GTP-binding protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer; Cancer pain